56 related articles for article (PubMed ID: 8947974)
1. Vancomycin-binding characteristics in patients with serious infections.
Li L; Miles MV; Lakkis H; Zaritsky AL
Pharmacotherapy; 1996; 16(6):1024-9. PubMed ID: 8947974
[TBL] [Abstract][Full Text] [Related]
2. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia.
Jeffres MN; Isakow W; Doherty JA; Micek ST; Kollef MH
Clin Ther; 2007 Jun; 29(6):1107-15. PubMed ID: 17692725
[TBL] [Abstract][Full Text] [Related]
3. Variability in teicoplanin protein binding and its prediction using serum albumin concentrations.
Yano R; Nakamura T; Tsukamoto H; Igarashi T; Goto N; Wakiya Y; Masada M
Ther Drug Monit; 2007 Aug; 29(4):399-403. PubMed ID: 17667792
[TBL] [Abstract][Full Text] [Related]
4. Daptomycin versus vancomycin for complicated skin and skin structure infections: clinical and economic outcomes.
Davis SL; McKinnon PS; Hall LM; Delgado G; Rose W; Wilson RF; Rybak MJ
Pharmacotherapy; 2007 Dec; 27(12):1611-8. PubMed ID: 18041881
[TBL] [Abstract][Full Text] [Related]
5. Clinical laboratory-based assay methodologies may underestimate and increase variability of vancomycin protein binding in hospitalized patients.
Crandon JL; MacVane SH; Nicolau DP
Pharmacotherapy; 2014 Feb; 34(2):203-9. PubMed ID: 23798336
[TBL] [Abstract][Full Text] [Related]
6. Valproate protein binding following rapid intravenous administration of high doses of valproic acid in patients with epilepsy.
Dutta S; Faught E; Limdi NA
J Clin Pharm Ther; 2007 Aug; 32(4):365-71. PubMed ID: 17635338
[TBL] [Abstract][Full Text] [Related]
7. Prevention of peritransplantation viridans streptococcal bacteremia with early vancomycin administration: a single-center observational cohort study.
Jaffe D; Jakubowski A; Sepkowitz K; Sebti R; Kiehn TE; Pamer E; Papanicolaou GA
Clin Infect Dis; 2004 Dec; 39(11):1625-32. PubMed ID: 15578362
[TBL] [Abstract][Full Text] [Related]
8. Increasing incidence of methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: reconsideration of empiric antimicrobial therapy.
Awad SS; Elhabash SI; Lee L; Farrow B; Berger DH
Am J Surg; 2007 Nov; 194(5):606-10. PubMed ID: 17936421
[TBL] [Abstract][Full Text] [Related]
9. Cefazolin plasma protein binding saturability during pregnancy.
Allegaert K; Van Mieghem T; Verbesselt R; Vanhole C; Devlieger R; Cossey V; Deprest J; de Hoon J
Methods Find Exp Clin Pharmacol; 2009; 31(1):25-8. PubMed ID: 19357795
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy.
Ingram PR; Lye DC; Tambyah PA; Goh WP; Tam VH; Fisher DA
J Antimicrob Chemother; 2008 Jul; 62(1):168-71. PubMed ID: 18334494
[TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of a model for predicting etoposide plasma protein binding in cancer patients.
Stewart CF; Fleming RA; Arbuck SG; Evans WE
Cancer Res; 1990 Nov; 50(21):6854-6. PubMed ID: 2208152
[TBL] [Abstract][Full Text] [Related]
12. Vancomycin dosage requirements among pediatric intensive care unit patients with normal renal function.
Glover ML; Cole E; Wolfsdorf J
J Crit Care; 2000 Mar; 15(1):1-4. PubMed ID: 10757191
[TBL] [Abstract][Full Text] [Related]
13. Economic benefit of appropriate timing of vancomycin prophylaxis in patients undergoing cardiovascular surgery.
Garey KW; Amrutkar P; Dao-Tran TK; Frost CP; Chen H; Essien EJ; Gentry LO
Pharmacotherapy; 2008 Jun; 28(6):699-706. PubMed ID: 18503397
[TBL] [Abstract][Full Text] [Related]
14. Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study.
Markou N; Markantonis SL; Dimitrakis E; Panidis D; Boutzouka E; Karatzas S; Rafailidis P; Apostolakos H; Baltopoulos G
Clin Ther; 2008 Jan; 30(1):143-51. PubMed ID: 18343250
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinectics of vancomycin and amikacin in the subeschar tissue fluid in patients with severe burn.
Yang RH; Rong XZ; Hua R; Zhang T
Burns; 2009 Feb; 35(1):75-9. PubMed ID: 18789586
[TBL] [Abstract][Full Text] [Related]
16. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.
Lodise TP; Patel N; Lomaestro BM; Rodvold KA; Drusano GL
Clin Infect Dis; 2009 Aug; 49(4):507-14. PubMed ID: 19586413
[TBL] [Abstract][Full Text] [Related]
17. Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections.
McKinnon PS; Sorensen SV; Liu LZ; Itani KM
Ann Pharmacother; 2006 Jun; 40(6):1017-23. PubMed ID: 16720705
[TBL] [Abstract][Full Text] [Related]
18. Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin.
Hermida J; Tutor JC
Ther Drug Monit; 2006 Jun; 28(3):326-31. PubMed ID: 16778715
[TBL] [Abstract][Full Text] [Related]
19. 'In vitro' binding of propofol to serum lipoproteins in thyroid dysfunction.
de la Fuente L; Lukas JC; Vázquez JA; Jauregizar N; Calvo R; Suárez E
Eur J Clin Pharmacol; 2002 Dec; 58(9):615-9. PubMed ID: 12483454
[TBL] [Abstract][Full Text] [Related]
20. Factors impacting unbound vancomycin concentrations in different patient populations.
Oyaert M; Spriet I; Allegaert K; Smits A; Vanstraelen K; Peersman N; Wauters J; Verhaegen J; Vermeersch P; Pauwels S
Antimicrob Agents Chemother; 2015 Nov; 59(11):7073-9. PubMed ID: 26349820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
